J Alzheimers Dis.
Formal publication: 2020
Authors: Gada Musa 1 2 3, Andrea Slachevsky 1 4 5 6, Carlos Muñoz-Neira 5 7, Carolina Méndez-Orellana 8, Roque Villagra 1 4, Christian González-Billault 4 9 10, Agustín Ibáñez 11 12 13 14 15, Michael Hornberger 16, Patricia Lillo 4 17
Abstract: Alzheimer’s disease (AD) and frontotemporal dementia (FTD) are the most common neurodegenerative early-onset dementias. Despite the fact that both conditions have a very distinctive clinical pattern, they present with an overlap in their cognitive and behavioral features that may lead to misdiagnosis or delay in diagnosis. The current review intends to summarize briefly the main differences at the clinical, neuropsychological, and behavioral levels, in an attempt to suggest which aspects would facilitate an adequate diagnosis in a clinical setting, especially in Latin American and low- and middle-income countries, where the resources needed for a differential diagnosis (such as MRI or biomarkers) are not always available. A timely diagnosis of AD and FTD have significant implications for the medical management and quality of life of patients and careers.
The Brain Health Diplomat’s Toolkit: supporting brain health diplomacy leaders in Latin America and the Caribbean
Navigating the multiple dimensions of the creativity-mental disorder link: a Convergence Mental Health perspective
Global South research is critical for understanding brain health, ageing and dementia
The Human Affectome